HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Pulls Aleve Ads Touting Parity With Rx Drugs At NAD’s Request

This article was originally published in The Tan Sheet

Executive Summary

Bayer will stop airing radio and TV ads for Aleve with the statement, "Prescription-strength relief without a prescription," following a recent National Advertising Division inquiry

You may also be interested in...



Naproxen Could Serve As NSAID Safety Trial Standard, Advisory Panel Says

Naproxen should be excluded from any cardiovascular warnings required for NSAIDs, FDA's joint panel on COX-2 safety recommended Feb. 18

Bayer Extra Strength Parity Claims With Rx Tylenol Upheld By NAD

An Extra Strength Bayer Aspirin Gelcaps ad claim stating it provides pain relief equivalent to prescription Tylenol with Codeine #3 is supported by scientific evidence, the National Advertising Division of the Council of Better Business Bureaus concludes in the May NAD Case Reports.

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

RS127140

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel